CD4 and cancer: Building on the findings of HOXA9 expression with respect to immune subtypes, we conducted an extensive analysis to investigate its association with various immune cells, including CD4+ T cells, CD8+ T cells, B cells, dendritic cells, macrophages, and natural killer (NK) cells, in 11 TCGA cancer types.